OÜ ENDOKRINOLOOGIAKESKUSRegistered
Key figures
320 850 €+1,5%
Revenue 2025
+35,9%
Average annual growth 2019–2025
Ratios
202553,2%
Profit margin
69,6%
EBITDA margin
99,9%
Equity ratio
740×
Current ratio
95,0%
Return on equity
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 65 073 € | 3 | 0 € |
| Q1 2026 | 99 514 € | 3 | 0 € |
| Q4 2025 | 82 644 € | 2 | 0 € |
| Q3 2025 | 37 457 € | 2 | — |
| Q2 2025 | 105 588 € | 2 | 0 € |
| Q1 2025 | 76 896 € | 2 | — |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
Distributed as dividends 160 000 € (96% of distributable profit).
History
2025160 000 €
2024189 411 €
2023163 442 €
202271 197 €
20210 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 65 501 | 47 789 | 76 625 | 175 987 | 197 142 | 123 916 | 133 936 |
| Total non-current assets | 5086 | 3110 | 0 | 0 | 0 | 53 554 | 45 898 |
| Total assets | 70 587 | 50 899 | 76 625 | 175 987 | 197 142 | 177 470 | 179 834 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 8214 | 1085 | 2439 | 7804 | 470 | 8425 | 181 |
| Non-current liabilities | — | — | — | — | — | — | — |
| Total liabilities | 8214 | 1085 | 2439 | 7804 | 470 | 8425 | 181 |
| Share capital | 2570 | 2570 | 2570 | 2570 | 2570 | 2570 | 2570 |
| Retained earnings of previous periods | 52 212 | 59 528 | 46 987 | 162 | 1914 | 4434 | 6218 |
| Profit for the year | 7334 | −12 541 | 24 372 | 165 194 | 191 931 | 161 784 | 170 608 |
| Reserves and other equity | 257 | 257 | 257 | 257 | 257 | 257 | 257 |
| Total equity | 62 373 | 49 814 | 74 186 | 168 183 | 196 672 | 169 045 | 179 653 |
| Income statement | |||||||
| Sales revenue | 51 024 | 13 799 | 55 507 | 242 113 | 288 559 | 316 040 | 320 850 |
| Operating profit | 7326 | −12 542 | 24 369 | 165 186 | 191 919 | 204 711 | 215 729 |
| EBITDA | 9402 | −10 566 | 27 479 | 165 186 | 191 919 | 206 799 | 223 385 |
| Profit before income tax | 7334 | −12 541 | 24 372 | 165 194 | 191 931 | 204 721 | 215 736 |
| Profit for the reporting year | 7334 | −12 541 | 24 372 | 165 194 | 191 931 | 161 784 | 170 608 |
| Labour costs | 9571 | 1802 | 1793 | 2165 | 0 | 0 | 0 |
| Depreciation of non-current assets | 2076 | 1976 | 3110 | 0 | 0 | 2088 | 7656 |
| Other indicators | |||||||
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Calculated dividend | — | 0 | 0 | 71 197 | 163 442 | 189 411 | 160 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Specialist medical care